All analyses

GE HealthCare Technologies Inc. (GEHC) Stock Analysis

Score A

Value · Grade C · Unknown

Healthcare · Medical Devices

$61.86

Fair Value

$75.61

+22.2%

Conviction

7/10

Quality

C

Classification

Value

Investment Thesis

Good opportunity: Solid company with good risk/reward at 2.9:1.

For New Investors

Quantitative score: high

For Current Holders

Quantitative score: neutral

Buy if

  • Price drops 15-20% (improves asymmetry)
  • Bull scenario catalysts materialize
  • Market-wide correction creates opportunity

Sell if

  • Bear scenario triggers occur
  • Quality metrics deteriorate (ROIC declining)
  • Better alternatives emerge

Valuation

Fair Value estimate: $75.61 (+22.2%). Significantly undervalued.

PEG-Based EPS

$74.98

FCF DCF Model

$80.42

EV/EBITDA

$68.31

Blended Fair Value

$75.61

Confidence

High

Methods

PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA

Quality Analysis

C

73/120 points

Investable

ROE (3Y Avg)

21.9%

ROIC-WACC Spread

0.1%

D/E Ratio

1.0x

Current Ratio

1.2x

Interest Coverage

6x

FCF Positive Years

3/3

Quality Flags

  • ROIC spread: 0.1pp (got 0/25 pts)
  • Leverage: D/E 1.0x (8/15 pts)

Market Sentiment

Wall Street Consensus

$85.00

+37.4% Upside

19 analysts

Range: $65.00$105.00

Rating: Buy

Our model aligns with Wall Street consensus.

Trend & Technical

Unknown

Insufficient data to calculate SMA 200.

Technical Score0/100

Technical analysis unavailable

Risk & Reward

Asymmetry Ratio

2.89:1

Expected Return

+11.9%

Bull Upside

+35.1%

Bear Downside

-12.2%

Good asymmetry: 2.89:1 ratio. Upside justifies risk.

Verdict: Favorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of GEHC?

Based on our multi-method conviction analysis, the estimated fair value of GE HealthCare Technologies Inc. (GEHC) is $75.61. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is high.

Is GEHC a buy, sell, or hold?

GEHC currently has a BUY rating with a conviction score of 7/10. Good opportunity: Solid company with good risk/reward at 2.9:1. Quantitative score: high.

Is GEHC a high-quality stock?

GE HealthCare Technologies Inc. has a quality grade of C (73/120 points), rated as Investable. Key metrics include ROE of 21.9%, ROIC-WACC spread of 0.1%, and D/E ratio of 1.0x.

What type of stock is GEHC?

GEHC is classified as a "value" in our framework. Low dividend (reinvesting): 0.2%, Low P/E: 14.8x, Mature growth: 3.8%, Market-like beta: 0.87, Consistent FCF: 3/3 years positive

What do Wall Street analysts say about GEHC?

19 Wall Street analysts have a consensus price target of $85.00 for GEHC, representing +37.4% upside. Targets range from $65.00 to $105.00. The consensus recommendation is "Buy". Our model aligns with Wall Street consensus.

What are the risks of investing in GEHC?

The risk/reward asymmetry ratio for GEHC is 2.89:1, rated as Favorable. Good asymmetry: 2.89:1 ratio. Upside justifies risk. The expected return is +11.9%, with bull case upside of +35.1% and bear case downside of -12.2%.

What is the current trend for GEHC?

GEHC is in a unknown trend. Insufficient data to calculate SMA 200. The technical score is —/100.

Related Stock Analyses

Best Stocks to Buy

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.